GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Short-Term Debt

Baskhanbiopharma (XKRX:354390) Short-Term Debt : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Short-Term Debt?

Baskhanbiopharma's Short-Term Debt for the quarter that ended in Dec. 2024 was ₩0 Mil.


Baskhanbiopharma Short-Term Debt Historical Data

The historical data trend for Baskhanbiopharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Short-Term Debt Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
2,384.15 - - - -

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt 2,384.15 - - - -

Baskhanbiopharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Baskhanbiopharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Baskhanbiopharma Business Description

Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines